Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-26

Clinical Trial Update: Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics

View source ↗

Summary

A completed clinical trial report examining genome-wide gene expression profiling in patients with immune thrombocytopenia treated with thrombopoietin mimetics.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nplate (romiplostim)
  • Promacta (eltrombopag)

Snippet

Sponsor: Stanford University | Conditions: Immune Thrombocytopenia | Status: COMPLETED